Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 457
Ph III recruiting: 55
Growth YoY: −4.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 651–700 of 962 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00319748	Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers	completed	Phase 2	15	Masonic Cancer Center, University of MinnesotaOTHER	1	Aug 26, 2019	clinicaltrials
NCT01132820	Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer	completed	Phase 2	53	National Cancer Institute (NCI)NIH	1	Aug 8, 2019	clinicaltrials